2017 annual financial data

Rigel Pharmaceuticals 2017 Financial results

Rigel Pharmaceuticals 2017 financial results with verified reported values.

Direct answer

Revenue was 4,484,000 USD.

Operating income was -79,616,000 USD and net income was -77,992,000 USD.
Operating cash flow was -77,557,000 USD.

Get free Rigel Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4,484,000 USD
Operating income
-79,616,000 USD
Net income
-77,992,000 USD
Operating cash flow
-77,557,000 USD